Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-30

Clinical Trial Update: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating prednisone for remission in granulomatosis with polyangiitis has completed, under a Centers of Excellence approach.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Granulomatosis With Polyangiitis | Phase 3 | Status: COMPLETED